Recently, Wu et al. and You et al. reported the distinct prognostic values of ALDH1 isoenzymes in breast cancer and non-small-cell lung cancer (NSCLC), respectively [16, 17], providing a comprehensive illustration of the prognostic value of individual ALDH1 isoenzymes. This evidence concerns the gene ALDH1A1 and breast carcinoma.